Experimental Study on SOD, GSH-Px, CAT, MDA Effects in Mice Liver and Brain Tissue of KOTAIS
Xue Wang
Abstract
Xue Wang
Abstract
Objective To study the anti-aging effects of KOTAIS on model mice by measuring SOD, GSH-Px, CAT, MDA levels of liver and brain tissue. Methods Random groups were prepared by weight for 5 groups and were given normal, D-galactose, and the low, middle and high dose of KOTAIS. Interrelated senile indexes were measured after successively given medicine for 60 days. Results Every dose group is able to improve the activities of SOD and CAT and GSH-Px and decrease the level of MDA in the liver of all mice. The effects of anti-aging is very obvious for low and middle dose groups. Conclusion KOTAIS has anti-aging effects by eliminating free radicals.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the anti-aging effects of KOTAIS on model mice by measuring SOD, GSH-Px, CAT, MDA levels of liver and brain tissue. Methods Random groups were prepared by weight for 5 groups and were given normal, D-galactose, and the low, middle and high dose of KOTAIS. Interrelated senile indexes were measured after successively given medicine for 60 days. Results Every dose group is able to improve the activities of SOD and CAT and GSH-Px and decrease the level of MDA in the liver of all mice. The effects of anti-aging is very obvious for low and middle dose groups. Conclusion KOTAIS has anti-aging effects by eliminating free radicals.
Key concepts: Medicine, Brain tissue, Liver tissue, Internal medicine, Endocrinology